Mihaly Balogh
Overview
Explore the profile of Mihaly Balogh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
646
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Regalado C, Balogh M
Front Mol Biosci
. 2024 Dec;
11:1451611.
PMID: 39664453
As chemotherapy is still a cornerstone of colorectal cancer (CRC) treatment, chemotherapy-induced peripheral neuropathy (CIPN) presents significant clinical challenges, affecting millions worldwide. A subset of colon cancer patients (approximately 30%)...
2.
Karadi D, Galambos A, Lakatos P, Apenberg J, Abbood S, Balogh M, et al.
Int J Mol Sci
. 2023 May;
24(9).
PMID: 37175678
Despite the large arsenal of analgesic medications, neuropathic pain (NP) management is not solved yet. Angiotensin II receptor type 1 (AT1) has been identified as a potential target in NP...
3.
Balogh M, Zhang J, Gaffney C, Kalakuntla N, Nguyen N, Trinh R, et al.
J Neuroinflammation
. 2022 Aug;
19(1):204.
PMID: 35962398
Reports of neurological sequelae related to colon cancer are largely restricted to rare instances of paraneoplastic syndromes, due to autoimmune reactions. Systemic inflammation associated with tumor development influences sensory neuron...
4.
Kiraly K, Karadi D, Zador F, Mohammadzadeh A, Galambos A, Balogh M, et al.
Molecules
. 2021 Oct;
26(20).
PMID: 34684749
The current protocols for neuropathic pain management include µ-opioid receptor (MOR) analgesics alongside other drugs; however, there is debate on the effectiveness of opioids. Nevertheless, dose escalation is required to...
5.
Balogh M, Janjic J, Shepherd A
Antioxid Redox Signal
. 2021 Aug;
36(1-3):122-143.
PMID: 34416821
Diabetes is a major source of neuropathy and neuropathic pain that is set to continue growing in prevalence. Diabetic peripheral neuropathy (DPN) and pain associated with diabetes are not adequately...
6.
Balogh M, Aguilar C, Nguyen N, Shepherd A
Pain Rep
. 2021 May;
6(1):e869.
PMID: 33981922
Growing evidence implicates the renin-angiotensin system (RAS) in multiple facets of neuropathic pain (NP). This narrative review focuses primarily on the major bioactive RAS peptide, Angiotensin II (Ang II), and...
7.
Lazar B, Laszlo S, Hutka B, Toth A, Mohammadzadeh A, Berekmeri E, et al.
Biochem Pharmacol
. 2021 May;
190:114590.
PMID: 33940029
It has been proposed that changes in microbiota due to nonsteroidal anti-inflammatory drugs (NSAIDs) alter the composition of bile, and elevation of hydrophobic secondary bile acids contributes to small intestinal...
8.
Mohammadzadeh A, Lakatos P, Balogh M, Zador F, Karadi D, Zadori Z, et al.
Int J Mol Sci
. 2021 Apr;
22(5).
PMID: 33804568
The limited effect of current medications on neuropathic pain (NP) has initiated large efforts to develop effective treatments. Animal studies showed that glycine transporter (GlyT) inhibitors are promising analgesics in...
9.
Laszlo S, Lazar B, Brenner G, Makkos A, Balogh M, Al-Khrasani M, et al.
Biochem Pharmacol
. 2020 Jun;
178:114099.
PMID: 32540483
There is some recent evidence that cardiac ischemia/reperfusion (I/R) injury induces intestinal damage within days, which contributes to adverse cardiovascular outcomes after myocardial infarction. However, it is not clear whether...
10.
Furst S, Zadori Z, Zador F, Kiraly K, Balogh M, Laszlo S, et al.
Molecules
. 2020 May;
25(11).
PMID: 32466522
There is growing evidence on the role of peripheral µ-opioid receptors (MORs) in analgesia and analgesic tolerance. Opioid analgesics are the mainstay in the management of moderate to severe pain,...